Paul W. Sauer
Corporate Officer/Principal chez VAXCYTE, INC.
Fortune : 517 243 $ au 31/03/2024
Provenance du réseau au premier degré de Paul W. Sauer
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 31 | |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
26
| Extinct | Pharmaceuticals: Major | 26 |
| Subsidiary | Pharmaceuticals: Major | 12 | |
Igenica Biotherapeutics, Inc.
 Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA.
5
| Extinct | Pharmaceuticals: Major | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Paul W. Sauer via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing Public Communications Contact | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal President Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Investor Relations Contact Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Founder Director/Board Member General Counsel | |
| NEOGENOMICS, INC. | Medical/Nursing Services | Director of Finance/CFO General Counsel | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
| CORCEPT THERAPEUTICS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal Director/Board Member Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Dartmouth College | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the private company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| The University of Chicago | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Masters Business Admin | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
| University of Wisconsin | College/University | Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Illinois | College/University | Doctorate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| PDL BIOPHARMA, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chairman Chief Tech/Sci/R&D Officer Human Resources Officer President Chief Executive Officer Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal General Counsel General Counsel General Counsel | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member Founder General Counsel Corporate Officer/Principal | |
| ICOSAVAX, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Orbus Therapeutics, Inc.
 Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| New York University School of Law | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| NKARTA, INC. | Biotechnology | Chief Executive Officer General Counsel Chief Administrative Officer | |
| DERMIRA, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member | |
| MODERNA, INC. | Biotechnology | Human Resources Officer Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Graduate Degree | |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| ITERUM THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 46 |
| Royaume-Uni | 3 |
| Canada | 2 |
| Allemagne | 2 |
| Irlande | 2 |
Sectorielle
| Health Technology | 32 |
| Consumer Services | 14 |
| Commercial Services | 4 |
| Health Services | 3 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 417 |
| Corporate Officer/Principal | 212 |
| Independent Dir/Board Member | 120 |
| Undergraduate Degree | 55 |
| Chairman | 52 |
Relations les plus connectées
| Insiders | |
|---|---|
| Jon Saxe | 43 |
| Heath Lukatch | 43 |
| Patrick Heron | 42 |
| Patrick Enright | 41 |
| Mark McDade | 35 |
| Kurt von Emster | 34 |
| Helen Kim | 33 |
| Deepa Pakianathan | 32 |
| Terry Gould | 26 |
| Leonard Patrick Gage | 26 |
| Paul Hastings | 24 |
| Moncef Slaoui | 22 |
| Karen Dawes | 21 |
| Denise Scots-Knight | 20 |
| Robert Hopfner | 20 |
- Bourse
- Insiders
- Paul W. Sauer
- Connexions Sociétés
